Dermatology
Parent: Medical Student Research Forum Posters
eScholarship stats: Breakdown by Item for July through October, 2026
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 8ns0f977 | Can PRAME immunohistochemistry be used to differentiate sebaceous carcinoma from basal cell carcinoma? | 220 | 133 | 87 | 60.5% |
| 9js520gj | How Do FDA approved Biologics Compare to Narrow-Band Ultra-Violet B Light for the treatment of moderate to severe Psoriasis and AtopicDermatitis? | 204 | 77 | 127 | 37.7% |
| 05h7c8np | The association between juvenile xanthogranulomas in neurofibromatosis type 1 patients and the development of leukemia: A systematic review | 180 | 27 | 153 | 15.0% |
| 1927k0vt | Risk Assessment of Internal Malignancies in Patients with Vitiligo | 120 | 32 | 88 | 26.7% |
| 9nx766zd | Localized, Alopecic Myxedema of the Scalp | 106 | 56 | 50 | 52.8% |
| 7j09h97k | Comparison of S100A8 and PRAME as biomarkers for diagnosing melanoma | 90 | 21 | 69 | 23.3% |
| 8717299s | CHARACTERIZING PATIENTS WITH DERMATOMYOSITIS FROM 2011-2021 AT A TERTIARY CARE CENTER | 86 | 27 | 59 | 31.4% |
| 8kv2h76p | Mohs micrographic surgery versus wide local excision for the treatment of atypical fibroxanthoma: a retrospective cohort study | 84 | 36 | 48 | 42.9% |
| 0gh2p8mw | TRPM4 Promotes Psoriasiform Dermatitis (PsD) and is a Potential Therapeutic Target for Psoriasis | 81 | 45 | 36 | 55.6% |
| 4bk9f86p | How Do FDA approved Biologics Compare to Narrow-Band Ultra-Violet B Light for the treatment of moderate to severe Psoriasis and Atopic Dermatitis? | 77 | 29 | 48 | 37.7% |
| 6s70m9x1 | Epidermal Nevus with Extensive Cutaneous Involvement | 77 | 24 | 53 | 31.2% |
| 8x99z6nm | The association between juvenile xanthogranulomas in neurofibromatosis type 1 patients and the development of leukemia: A systematic review | 77 | 43 | 34 | 55.8% |
| 5sv5n5qt | Analyzing Patient-Provider Communication Characteristics After Mohs Micrographic Surgery (MMS) | 74 | 18 | 56 | 24.3% |
| 3tj5638c | Mutational landscape of melanocytic tumorsfrom patients with RASopathies | 59 | 18 | 41 | 30.5% |
| 610324t0 | Characterizing disease manifestations and mortality of systemic sclerosis at UC Davis by race/ethnicity | 55 | 20 | 35 | 36.4% |
| 8zv331ww | Nipple thrush or dermatitis: a retrospective cohort study of nipple-areolar complex conditions and call for coordinated, multidisciplinary care | 55 | 20 | 35 | 36.4% |
| 3041586k | Identification of psoriasis-protective <em>IL17D</em> variant associated with increased <em>IL17D</em> and <em>FAM19A5</em> expression in psoriatic skin | 54 | 15 | 39 | 27.8% |
| 0zg4p3vq | The influence of p16 immunohistochemistry on diagnosis and management recommendation of melanocytic neoplasms by dermatopathologists: A single institution prospective study | 50 | 20 | 30 | 40.0% |
| 6tm4g3v1 | Effect of Body Mass Index on Cutaneous Malignancy Screenings at Dermatology Visits | 50 | 17 | 33 | 34.0% |
| 1jw7x1f7 | Managing Aggressive CD30-Positive Lymphoproliferative Disorder and Toward Early Palliative Care Inclusion | 40 | 17 | 23 | 42.5% |
| 45t3x1vw | Do surgical closure techniques really effect the risk of surgical site infection (SSI) in dermatologic procedures? | 36 | 5 | 31 | 13.9% |
| 7hk7598k | Characteristics of patients with hidradenitis suppurativa seen at a tertiary care facility from 2009-2019: a retrospective chart review study | 36 | 7 | 29 | 19.4% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.